Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for CP/CPPS
NCT00371033Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) comparing Pregabalin with Placebo (2 arms). Primary endpoint: Decrease in the NIH-CPSI Total Score by at Least 6 Points at 6 weeks. Started Mar 2006; status: completed.
02
Drugs
pregabalin
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT00371033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371033.